Foley & Lardner LLP Partner Kyle Faget was quoted in the MedTech Dive article, “3 key FDA topics for medtechs in 2022,” about the October 2021 release of the FDA’s list of proposed draft and final medical device guidance documents for fiscal year 2022, including the final guidance on clinical decision support (CDS) software.
Faget said that “The risk-based approach to enforcement that FDA issued previously is not easy for [technology] developers to follow. FDA needs to provide more clarity for developers as to where the boundaries are for each one of those categories.”
Faget is co-chair of Foley’s Health Care and Life Sciences Practice Groups.
Related News
May 12, 2026
In the News
Foley's LearningLab Featured Across Media for On-Demand CLE Offerings
Foley & Lardner LLP's LearningLab, the firm's on-demand learning platform designed to help clients and other in-house counsel access and earn continuing legal education credit and additional business programming, is featured across the media.
May 8, 2026
In the News
Shannon Goff Kukulka Highlighted Across Media for Foley Arrival
Foley & Lardner LLP partner Shannon Goff Kukulka is featured across media for her recent arrival to the firm's Nashville office.
May 8, 2026
In the News
Gregory Husisian Shares Insight on US Trade Court Tariff Ruling
Foley & Lardner LLP partner Gregory Husisian was quoted in Logistics Management’s article, “CIT Court Rules White House’s 10% Tariffs Not Lawful,” exploring the recent U.S. Court of International Trade decision.